Skip to main content
Signal8

DOCHERTY JOHN MARTIN

SEC insider (Form 3/4/5 filer). CIK 0001638727. President at Lexaria Bioscience Corp. (LEXX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 29, 2025. Located in PORT PERRY, A6.

Companies DOCHERTY JOHN MARTIN has filed insider reports for

  • Lexaria Bioscience Corp. (LEXX): Director, Officer, President
DOCHERTY JOHN MARTIN profile photo

DOCHERTY JOHN MARTIN

CIK: 0001638727

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lexaria Bioscience Corp. logo
LEXX

Lexaria Bioscience Corp.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Lexaria Bioscience Corp. logo
    LEXX

    Lexaria Bioscience Corp.

    Jul 29, 2025
    Purchase
    Direct
    5.4K shares at avg. $0.93$5K
  • Lexaria Bioscience Corp. logo
    LEXX

    Lexaria Bioscience Corp.

    May 15, 2025
    Award

    Stock Options

    Direct
    150K shares-

1-2 of 2